Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2010. Start Trial.
Date Value
October 02, 2026 2.233B
October 01, 2026 2.150B
September 30, 2026 2.348B
September 29, 2026 2.186B
September 28, 2026 2.203B
September 25, 2026 2.207B
September 24, 2026 2.281B
September 23, 2026 2.188B
September 22, 2026 2.289B
September 21, 2026 2.158B
September 18, 2026 2.182B
September 17, 2026 2.190B
September 16, 2026 2.217B
September 15, 2026 2.142B
September 14, 2026 2.230B
September 11, 2026 2.193B
September 10, 2026 2.586B
September 09, 2026 2.679B
September 08, 2026 2.681B
September 04, 2026 2.661B
September 03, 2026 2.629B
September 02, 2026 2.721B
September 01, 2026 2.532B
August 31, 2026 2.556B
August 28, 2026 2.530B
Date Value
August 27, 2026 2.933B
August 26, 2026 2.635B
August 25, 2026 2.707B
August 24, 2026 2.755B
August 21, 2026 2.984B
August 20, 2026 2.568B
August 19, 2026 2.659B
August 18, 2026 2.507B
August 17, 2026 2.487B
August 14, 2026 2.443B
August 13, 2026 2.358B
August 12, 2026 2.239B
August 11, 2026 2.093B
August 10, 2026 2.091B
August 07, 2026 2.287B
August 06, 2026 2.225B
August 05, 2026 2.257B
August 04, 2026 2.247B
August 03, 2026 2.128B
July 31, 2026 1.884B
July 30, 2026 1.940B
July 29, 2026 1.902B
July 28, 2026 1.900B
July 27, 2026 2.050B
July 24, 2026 2.148B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AbbVie, Inc. 528.72B
Capricor Therapeutics, Inc. 373.19M
Alnylam Pharmaceuticals, Inc. 29.06B
Incyte Corp. 18.68B
Insmed, Inc. 23.84B

Enterprise Value Related Metrics